Morning Buzz: Exelixis, Inc. (EXEL), Alimera Sciences Inc (ALIM), Dreamworks Animation (DWA)
September 29, 2014 at 08:18 AM EDT
Shares of Exelixis, Inc. (EXEL) are up almost 23% to $1.91 in pre-market trading Monday after the company announced positive results from coBRIM, the phase 3 pivotal trial of cobimetinib, a specific MEK inhibitor discovered by Exelixis, in combination with vemurafenib in previously untreated patients with BRAF V600 Mutation-positive advanced melanoma. Exelixis, Inc. shares have […] View the full post at: Morning Buzz: Exelixis, Inc. (EXEL), Alimera Sciences Inc (ALIM), Dreamworks Animation (DWA) No related posts.